HK1156234A1 - Formulation containing phosphate derivatives of electron transfer agents - Google Patents

Formulation containing phosphate derivatives of electron transfer agents

Info

Publication number
HK1156234A1
HK1156234A1 HK11110534.9A HK11110534A HK1156234A1 HK 1156234 A1 HK1156234 A1 HK 1156234A1 HK 11110534 A HK11110534 A HK 11110534A HK 1156234 A1 HK1156234 A1 HK 1156234A1
Authority
HK
Hong Kong
Prior art keywords
electron transfer
formulation containing
transfer agents
containing phosphate
phosphate derivatives
Prior art date
Application number
HK11110534.9A
Other languages
English (en)
Chinese (zh)
Inventor
Simon Michael West
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR5499A external-priority patent/AUPR549901A0/en
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Publication of HK1156234A1 publication Critical patent/HK1156234A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
HK11110534.9A 2000-11-14 2011-10-06 Formulation containing phosphate derivatives of electron transfer agents HK1156234A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24799700P 2000-11-14 2000-11-14
AUPR5499A AUPR549901A0 (en) 2001-06-06 2001-06-06 Topical formulation containing tocopheryl phosphates

Publications (1)

Publication Number Publication Date
HK1156234A1 true HK1156234A1 (en) 2012-06-08

Family

ID=25646719

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110534.9A HK1156234A1 (en) 2000-11-14 2011-10-06 Formulation containing phosphate derivatives of electron transfer agents

Country Status (10)

Country Link
EP (1) EP1339412B1 (ko)
JP (2) JP4620326B2 (ko)
KR (1) KR100576289B1 (ko)
CN (1) CN100396287C (ko)
AU (1) AU2002214820B2 (ko)
BR (1) BR0115952B1 (ko)
CA (1) CA2426852C (ko)
HK (1) HK1156234A1 (ko)
MX (1) MXPA03003584A (ko)
WO (1) WO2002040033A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CN1547475B (zh) 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
KR20050089045A (ko) * 2002-12-19 2005-09-07 액세스 비지니스 그룹 인터내셔날 엘엘씨 수용성 비타민 ｅ에 의한 피부 세포 재생의 증가
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
DE602005025979D1 (de) * 2004-03-03 2011-03-03 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
DE602005025883D1 (de) * 2004-08-03 2011-02-24 Vital Health Sciences Pty Ltd Träger für die enterale verabreichung
WO2006092025A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having lipid lowering properties
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
AU2006220247B2 (en) * 2005-03-03 2011-08-25 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
ES2557475T3 (es) * 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
BR112012015682A2 (pt) * 2009-12-23 2019-09-24 Phosphagenics Ltd composição transportadora.
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
EP2531219A4 (en) * 2010-02-05 2015-01-14 Phosphagenics Ltd SUPPORT COMPOSITION
BR112012024835A2 (pt) 2010-03-30 2016-06-07 Phosphagenics Ltd adesivo de distribuição transdérmica
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
JP5993655B2 (ja) * 2011-10-26 2016-09-14 株式会社ファンケル 液晶組成物
DE102014019388A1 (de) * 2014-12-29 2016-06-30 Susanne Wagner Arzneimittel auf der Basis von Maghämit zur gleichzeitigen Reduzierung der gastrointestinalen Natriumresorption und Phosphatresorption
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
KR102647670B1 (ko) * 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5965750A (en) * 1995-10-17 1999-10-12 Showa Denko K.K. High- purity tocopherol phosphates, process for the preparation thereof, methods for analysis thereof, and cosmetics
JPH09309813A (ja) * 1996-05-22 1997-12-02 Nonogawa Shoji Kk 皮膚外用剤
JPH10155429A (ja) * 1996-11-27 1998-06-16 Showa Denko Kk 動物に対するビタミンｅ供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物
AUPP829399A0 (en) * 1999-01-25 1999-02-18 Swig Pty Ltd Recovery for chroman derivatives
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate

Also Published As

Publication number Publication date
JP2004516251A (ja) 2004-06-03
AU1482002A (en) 2002-05-27
JP2010241818A (ja) 2010-10-28
EP1339412A1 (en) 2003-09-03
JP4620326B2 (ja) 2011-01-26
KR100576289B1 (ko) 2006-05-04
BR0115952A (pt) 2003-09-16
AU2002214820B2 (en) 2003-08-14
MXPA03003584A (es) 2003-07-14
EP1339412B1 (en) 2011-11-02
CA2426852A1 (en) 2002-05-23
EP1339412A4 (en) 2004-12-15
KR20030062336A (ko) 2003-07-23
WO2002040033A1 (en) 2002-05-23
CA2426852C (en) 2010-01-26
BR0115952B1 (pt) 2017-10-24
CN100396287C (zh) 2008-06-25
CN1474698A (zh) 2004-02-11

Similar Documents

Publication Publication Date Title
HK1156234A1 (en) Formulation containing phosphate derivatives of electron transfer agents
EP1420797A4 (en) DERMAL THERAPY USING PHOSPHATE DERIVATIVES OF ELECTRONIC TRANSFER AGENTS
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
AU8533101A (en) Phosphate derivatives as immunoregulatory agents
HUP0203540A3 (en) Extended release formulations of erythromycin derivatives
HUP0104088A3 (en) Use of sustained release ranolazine formulations
AU2093101A (en) Compositions for efficient release of active ingredients
HUP0200899A3 (en) Soluble fertilizer formulation
HUP0302412A3 (en) Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU2001295657A1 (en) Formulation containing wax-esters
HUP0105463A3 (en) Controlled release formulation of divalproex sodium
HK1074163A1 (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
AU2001288277A1 (en) Compounds and compositions for delivering active agents
HK1051142A1 (en) Formulation of substituted benzimidazoles
AU2001270626A1 (en) Floating type formulation of agricultural agents
AU2203601A (en) Formulations of adenosine a1 agonists
IL148777A0 (en) New formulation of mirtazapine
GB0111594D0 (en) Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
IL136917A0 (en) Stabilization of lipid:dna formulations during nebulization
HK1047399A1 (zh) 羥乙磷酸二鈉口服劑
EP1233947A4 (en) PRODUCTION OF 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ON DERIVATIVES
AU2204001A (en) Formulations of adenosine a1 agonists
AU1155000A (en) Controlled-release formulations of metamizole
PL355625A1 (en) Use of formulations for treating surfaces for temporarily improving dirt-removing behavior

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20211113